Dampening antiviral immunity can protect the host

FEBS J. 2022 Feb;289(3):634-646. doi: 10.1111/febs.15756. Epub 2021 Feb 23.

Abstract

Viral infections are very common, and in most cases, the virus is well controlled and eliminated by the immune system. Nevertheless, in some cases, damage of the host tissue inflicted by the virus itself or by the elicited immune response may result in severe disease courses. Thus, regulatory mechanisms are necessary to control virus-induced and immune pathology. This ensures immune responses are elicited in a potent but controlled manner. In this review, we will outline how immune regulation may contribute to this process. We focus on regulatory T cells and co-inhibitory receptors and outline how these two regulatory immune components allow for and may even promote potent but not pathologic immune responses. By enabling a balanced immune response, regulatory mechanisms can thus contribute to pathogen control as well as tissue and host protection.

Keywords: antiviral immunity; co-inhibitory receptors; exhaustion; immune regulation; immunopathology; regulatory T cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Host-Pathogen Interactions / genetics*
  • Host-Pathogen Interactions / immunology
  • Humans
  • Immune System / immunology*
  • Immunity, Innate / genetics*
  • Immunity, Innate / immunology
  • T-Lymphocytes, Regulatory / immunology
  • Virus Diseases / drug therapy
  • Virus Diseases / genetics*
  • Virus Diseases / immunology
  • Virus Diseases / virology

Substances

  • Antiviral Agents